Where many generic pharmaceutical companies focus on a limited quantity of therapeutic areas and dosage forms, Florida Pharmaceutical Products, Inc., applies their strategic intelligence across multiple therapies and delivery systems.
The company’s ability to create innovative solutions that overcome competitive limitations of the generics market in the United States is a key strategic advantage enabling Florida Pharmaceutical Products, Inc., to optimize financial returns.
High costs to deliver a product to market, extensive FDA timelines for approvals and complex documentation create obstacles preventing business success.
Florida Pharmaceutical Products, Inc., removes hurdles with a lean organizational structure that lowers expenses, minimizes labor outlays and avoids fixed costs of conventional generics companies.
Experienced management provides informed and decisive action and the ability to adapt flexible solutions that react to situations ‘on-the-go,’